Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I am a ptsc shareholder for more than 10 years ....
"If the MMP is strong and valuable in that way, some users/longs seem to believe, why haven´t we seen any kind of a take-over bid, for example?"

A few years ago, at a SHAM, the PTSC BoD was asked whether they had sought or would seek a valuation of our share of the MMP. The question seemed to both surprise and confuse them. I don't believe it was answered.. Lack of valuation would seem to imply no intent or desire to consider acquisition as an option to provide shareholder value.
Share
New Message
Please login to post a reply